76 related articles for article (PubMed ID: 8042237)
1. The beneficial effect of dietary antioxidant supplementation on platelet aggregation and cyclosporine treatment in heart transplant recipients.
de Lorgeril M; Boissonnat P; Salen P; Monjaud I; Monnez C; Guidollet J; Ferrera R; Dureau G; Ninet J; Renaud S
Transplantation; 1994 Jul; 58(2):193-5. PubMed ID: 8042237
[TBL] [Abstract][Full Text] [Related]
2. Trapidil decreases the aggregation of platelets from heart transplant recipients ex vivo.
Jovin IS; Taborski U; Szalay Z; Friedel A; Segieth I; Jovin A; Heidinger K; Schreiner K; Frass O; Klövekorn WP; Müller-Berghaus G
Transplant Proc; 2006 Jun; 38(5):1523-5. PubMed ID: 16797349
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
[TBL] [Abstract][Full Text] [Related]
4. Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients.
Blackhall ML; Fassett RG; Sharman JE; Geraghty DP; Coombes JS
Nephrol Dial Transplant; 2005 Sep; 20(9):1970-5. PubMed ID: 15998657
[TBL] [Abstract][Full Text] [Related]
5. Short-term, moderate dosage Vitamin E supplementation may have no effect on platelet aggregation, coagulation profile, and bleeding time in healthy individuals.
Dereska NH; McLemore EC; Tessier DJ; Bash DS; Brophy CM
J Surg Res; 2006 May; 132(1):121-9. PubMed ID: 16337968
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine lymphocyte maximum level monitoring in de novo kidney transplant patients: a prospective study.
Barbari AG; Masri MA; Stephan AG; El Ghoul B; Rizk S; Mourad N; Kamel GS; Kilani HE; Karam AS
Exp Clin Transplant; 2006 Jun; 4(1):400-5. PubMed ID: 16827634
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral vitamin E and C therapy on calcineurin inhibitor levels in heart transplant recipients.
Lake KD; Aaronson KD; Gorman LE; Pagani FD; Koelling TM
J Heart Lung Transplant; 2005 Aug; 24(8):990-4. PubMed ID: 16102431
[TBL] [Abstract][Full Text] [Related]
8. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
9. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
[TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients.
Mathias HC; Ozalp F; Will MB; Borland W; Payne C; Kerr M; Lockhart J; Murday AJ
J Heart Lung Transplant; 2005 Dec; 24(12):2137-43. PubMed ID: 16364862
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant supplementation may improve renal transplant function: a preliminary report.
Loong CC; Chang YH; Wu TH; King KL; Yang WC; Wu CW; Lui WY
Transplant Proc; 2004 Oct; 36(8):2438-9. PubMed ID: 15561272
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral pyridoxine hydrochloride supplementation on in vitro platelet sensitivity to different agonists.
Sermet A; Aybak M; Ulak G; Güzel C; Denli O
Arzneimittelforschung; 1995 Jan; 45(1):19-21. PubMed ID: 7893263
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.
White M; Pelletier GB; Tan A; Jesina C; Carrier M
J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770
[TBL] [Abstract][Full Text] [Related]
14. Does short-course induction with OKT3 improve outcome after heart transplantation? A randomized trial.
Kobashigawa JA; Stevenson LW; Brownfield E; Moriguchi JD; Kawata N; Hamilton M; Minkely R; Drinkwater D; Laks H
J Heart Lung Transplant; 1993; 12(2):205-8. PubMed ID: 8476892
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.
Matetzky S; Fefer P; Shenkman B; Varon D; Savion N; Hod H
Am J Cardiol; 2008 Sep; 102(5):524-9. PubMed ID: 18721506
[TBL] [Abstract][Full Text] [Related]
17. Impact of cyclosporine A on magnesium homeostasis: clinical observation in lung transplant recipients and experimental study in mice.
Sabbagh F; El Tawil Z; Lecerf F; Hulin A; Maurois P; Dartevelle P; Bac P; German-Fattal M
Transplantation; 2008 Aug; 86(3):436-44. PubMed ID: 18698248
[TBL] [Abstract][Full Text] [Related]
18. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
19. Effects of immunosuppressive drugs on platelet aggregation and soluble P-selectin levels in renal transplant patients.
Sahin G; Akay OM; Kus E; Bal C; Yalcin AU; Gulbas Z
Ren Fail; 2009; 31(2):111-7. PubMed ID: 19212907
[TBL] [Abstract][Full Text] [Related]
20. Optimum maintenance trough levels of cyclosporine in heart transplant recipients given corticosteroid-free regimen.
Nohria A; Ehtisham J; Ramahi TM
J Heart Lung Transplant; 1998 Sep; 17(9):849-53. PubMed ID: 9773855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
